NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 756483 | SB-742864 | 0.0237269271456697 | 0.30373821 |
NSC 761822 | (Z)-3-((1-(4-fluorophenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)-5-methoxyindolin-2-one | 0.0237269271456697 | 0.06512762 |
NSC 761832 | (Z)-3-((1-(3,5-dimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)-5-methoxyindolin-2-one | 0.0237269271456697 | 0.045899802 |
NSC 90736 | Null | 0.0237269271456697 | 0.17432734 |
NSC 744989 | 7-methoxy-8-[(5-2-methoxy-4-[(E)-3-(2,4-dimethyl-3-quinolyl)-3-oxo-1-propenyl]phenoxybutyl)oxy]-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one | 0.0291420747327558 | 0.29503621 |
NSC 750685 | Null | 0.0291420747327558 | -0.036613537 |
NSC 76150 | Null | 0.0291420747327558 | 0.17644451 |
NSC 95466 | PCNU | 0.0291420747327558 | 0.34021921 |
NSC 104801 | Cytembena | 0.029142074732756 | 0.18198927 |
NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.029142074732756 | 0.4197023 |